Clinical trial
German Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.
NCT03135197 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- German Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.
- Lead sponsor
- University Hospital Muenster
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 8, 2017
- Completion date
- June 30, 2020
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.